Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.64
-0.58 (-9.32%)
At close: Nov 15, 2024, 4:00 PM
5.72
+0.08 (1.42%)
After-hours: Nov 15, 2024, 4:08 PM EST
Voyager Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 25.88 | 132.33 | -46.41 | -71.2 | 36.74 | -43.6 | |
| Depreciation & Amortization | 5.06 | 4.44 | 6.19 | 5.17 | 3.82 | 2.77 | |
| Loss (Gain) From Sale of Assets | 0.51 | 0.18 | 0.38 | - | - | - | |
| Asset Writedown & Restructuring Costs | 2.78 | - | - | - | - | 0.62 | |
| Loss (Gain) From Sale of Investments | -8.25 | -3.63 | -0.02 | 0.35 | 0.03 | -3.58 | |
| Stock-Based Compensation | 14.09 | 11.15 | 9.34 | 11.32 | 14.93 | 15.64 | |
| Other Operating Activities | - | - | -2.47 | -2.46 | -7.7 | -1.61 | |
| Change in Accounts Receivable | -16.42 | -83.23 | 0.48 | 7.28 | 10.48 | -18.5 | |
| Change in Accounts Payable | -0.11 | -0.96 | 1.99 | -0.06 | -3.44 | 2.6 | |
| Change in Unearned Revenue | -47.3 | 9.41 | 23.73 | -1.72 | -150.68 | 80.83 | |
| Change in Other Net Operating Assets | -0.78 | 8.23 | -5.73 | -2.21 | -0.91 | 13.51 | |
| Operating Cash Flow | -24.54 | 77.92 | -12.51 | -53.53 | -96.72 | 48.67 | |
| Capital Expenditures | -4.12 | -3.26 | -2.49 | -1.61 | -12.1 | -7.72 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.17 | |
| Investment in Securities | -36.7 | -138.39 | -4.85 | 67.52 | 125.09 | -82.93 | |
| Investing Cash Flow | -40.82 | -141.64 | -7.34 | 65.91 | 113 | -90.48 | |
| Issuance of Common Stock | 113.9 | 33.65 | 1.11 | 0.61 | 3.16 | 80.99 | |
| Financing Cash Flow | 113.9 | 33.65 | 1.11 | 0.61 | 3.16 | 80.99 | |
| Net Cash Flow | 48.54 | -30.08 | -18.74 | 12.99 | 19.44 | 39.18 | |
| Free Cash Flow | -28.66 | 74.66 | -15 | -55.13 | -108.81 | 40.95 | |
| Free Cash Flow Margin | -17.50% | 29.86% | -36.67% | -147.36% | -63.59% | 39.23% | |
| Free Cash Flow Per Share | -0.51 | 1.68 | -0.39 | -1.46 | -2.91 | 1.14 | |
| Levered Free Cash Flow | -19.75 | -3.01 | 4.13 | 3.94 | -19.99 | 3.08 | |
| Unlevered Free Cash Flow | -19.75 | -3.01 | 4.13 | 4.18 | -19.99 | 3.08 | |
| Change in Net Working Capital | 40.45 | 91.61 | -22.86 | -35.31 | 43.76 | -24.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.